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INTRODUCTION
Acute cholecystitis is one of the commonest surgicalemergencies. In the majority of cases, a stone impactedin the neck of the organ is the cause; resulting indistension, subsequent inflammation and bacterialinfection. Standard of care for patients presenting earlyin the course of their illness is an urgent surgicalintervention, which is laparoscopic cholecystectomy.1,2However, immediate surgery may not be possible insome patients due to presence of significant oruncontrolled comorbidities making simple laparoscopiccholecystectomy, a high risk undertaking in suchsituations.3,4 In these circumstances, percutaneous tubecholecystostomy is used as a temporizing measure as itallows for source control of the infection without anyincrease risk of a major surgical intervention.5,6 At present,this can be done very effectively under ultrasound guidance.
Combined with intravenous antibiotics, most of thesepatients can be managed successfully from the gall-bladder infection perspective. Once the sepsis resolves,definitive treatment in case of calculous cholecystitis isstill cholecystectomy. However, recent internationalliterature suggests that percutaneous cholecystectomymay be a valuable option for definitive treatment inselected high-risk patients with acute calculous chole-cystitis.7,8 For patients having acalculous cholecystitis,tube cholecystostomy is considered definitive treatment;8nevertheless for calculous cholecystitis, it is stilldebatable as to the need of subsequent surgeryafter percutaneous tube cholecystostomy, its timing andwhether interval surgery is technically more challenging.9
Only few studies have evaluated the efficacy and safetyof percutaneous tube cholecystostomy in the treatmentof acute cholecystitis, from this part of the world.10,11Also none of these studies specifically divulged the roleof percutaneous tube cholecystostomy in calculouscholecystitis. This study presents a retrospectivereview of patients, diagnosed to have acute calculouscholecystitis and treated with percutaneous cholecysto-stomy during a 5-year study period, at a tertiary carehospital in Pakistan.
The objective of this study was to evaluate the utility ofpercutaneous cholecystostomy tube in patients with
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acute calculus cholecystitis, who were considered unfitfor immediate surgery.
METHODOLOGY
A retrospective chart review, from January 2010 toDecember 2014 was undertaken at the Aga KhanUniversity Hospital, Karachi. The study proposal wasexempted by the Hospital Ethical Review Committee(3743-Sur-ERC-15). All patients above 16 years of age,who were diagnosed to have acute calculus cholecystitisand underwent percutaneous cholecystostomy tubeplacement, were included in the study. Patients wereidentified by the medical records department using theICD-9 coding system. Patients with cholecystostomytube insertion were divided into two groups, i.e. thosewho had interval cholecystectomy within 6 - 8 weeks oftube placement were put in group I and those who hadno further treatment were put in group II. The severity ofcholecystitis was assessed according to Tokyoguidelines.12 The inflammatory process was graded intogrades I, 2 and 3, according to the severity ofinflammation and organ dysfunction.
Data was analysed using SPSS version 20. Qualitativevariables were reported as percentages or proportionsand Chi-square test was used for comparative analysis.Quantitative variables were reported as mean (standarddeviation) and independent sample t-test was used foranalysis. However, data which did not follow the normaldistribution was reported as median (interquartile value)and Mann-Whitney U-test was used. A p-value of lessthan 0.05 was considered statistically significant.
RESULTS
Sixty-five patients were identified and included in thestudy. There were 44 (67.7%) males and 21 (32.3%)females. The mean age of patients was 58.5 +12 years.E. coli was the most common organism in bile culturesseen in 16 (24.6 %) patients. In 44 (67.7%) patients, bilecultures were negative. Forty-one (63.1%) patients werein the ASA III or IV category at presentation and 24(36.9%) were in the ASA II. Grade II was most commonseverity of cholecystitis, seen in 41 (63.1%) cases,followed by grade III in 22 (34%) patients. Patients werefollowed up for a mean of 19 +8 months in the medicalor surgical outpatient clinics. All patients had their tubesremoved as shown in Table I.
Forty-three patients (Group I) underwent an intervalcholecystectomy. The remaining 22 (Group II) weremanaged non-operatively; of these, 3 patients expiredduring their index admission and were excluded fromfurther analysis.
All 43 patients in Group I had attempted laparoscopiccholecystectomy. In five patients, this had to beconverted to an open procedure due to difficultdissection, giving a conversion rate of 11%. The median
operative time was 120 minutes (interquartile range =91-75 minutes). Two patients had CBD injuries duringlaparoscopic procedure (4.5%). One was managed withintraoperative CBD repair over T-tube, the other withpost-procedure ERCP and stenting. Seven patientsdeveloped surgical site infection.
Of the 19 patients in Group II, during follow-up, threedeveloped symptoms that needed intervention. Two patientshad attacks of pancreatitis, one at 6th month and the otherin the 2nd year. One needed an ERCP and laparoscopiccholecystectomy; the other was managed with ERCP andpapillotomy alone. The third patient developed acutecholecystitis 4 years after removal of tube. This wasmanaged successfully with antibiotics as the patient refusedintervention.
On comparing the two groups apart from age (Group I=55.3vs. Group II=64 years, p=0.006), no other significant
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Table I: Demographics.
Variable N=65n (%)





DM II 38 (58.5)
Hypertension 33 (50.8)
Ischemic heart disease 15 (23.1)
CKD 6 (9.2)
Other comorbids 14 (21.5) 
ASA level
I / II 24 (36.9)
III / IV 41 (63.1)
Hospital stay** (days) 5 (4 - 7)




Follow-up* (months) 19 +8
Cholecystogram 44 (67.7)
*mean, standard deviation;   **median, (interquartile value).
Table II: Comparison of Group I and II.
Variable Group I Group II p-valueN=43 N=22n (%) n (%)
Age * (years) 55.3 +11.4 64 +11.5 0.006
Gender
Male 31 (72.1) 13 (59.1) 0.401
Comorbid 35 (81.4) 18 (81.8) 1.000
ASA Level
III or IV   24 (55.8) 17 (77.3) 0.109
Grade of acute cholecystitis
Grade I or II 31 (72.1) 13 (59.1) 0.401
Grade III 12 (27.9) 9 (40.9)
Duration of tube placement** 45 (40 - 58) 38 (26.25 - 57) 0.068,  U=306(days)
Hospital stay**  (days) 5 (4 - 7) 5.5 (4 - 9.25) 0.253,  U=391
* Mean standard deviation; ** median (interquartile value).
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difference was found with regard to gender, comorbids,ASA level, grade of acute cholecystitis, duration of tubeplacement, and hospital stay (as shown in Table I).
DISCUSSION
For the majority of patients presenting with acute calculuscholecystitis, an urgent laparoscopic cholecystectomywould be the treatment of choice.2 In patient deemedunfit to undergo immediate surgery, due to associatedmedical conditions, the acute infection can be success-fully aborted in over 90% of cases by percutaneous tubedecompression of the distended gallbladder andjudicious antibiotic usage.
The need for an interval cholecystectomy in acute calculuscholecystitis, successfully treated non-operatively, isunclear. There are no randomised studies addressingthis area, the general consensus of opinion in literaturebeing that surgery is offered to patients fit to undergothe procedure. In patients having acalculus acutecholecystitis, tube cholecystostomy can be used asdefinitive treatment.8
In this study, 65% of patients with acute calculuscholecystitis initially managed with a percutaneous tubecholecystostomy, subseqently underwent surgery. Allhad attempted a laparoscopic procedure. In 89%, theprocedure was successfully completed as planned. In11%, the procedure had to be converted due to denseadhesions and distorted anatomy. The expected conversionrate for elective laparoscopic cholecystectomy is about1-4%.13,14 The average procedure time for this groupwas also more than expected for elective procedures onthe gallbladder 130 +58 minutes compared to averagetime in literature of 60-90 minutes. Similarly, theincidence of CBD injury in this group was 4.8% (2/44), aproportion much higher than seen in elective gallbladdersurgeries.15
Out of the 19 patients in group II, 15.7% (3/19) developedsymptoms related to gallstones. In two, interventionswere needed, the third successfully managed withantibiotics. In a retrospective review, it is not possible toidentify the exact reason why elective surgery was notoffered in this group but it is probably safe to presumethat the patients' health status and willingness toundergo the operation were important factors.
In literature the proportion of this subgroup, i.e. whorelapse after tube removal, is variable from 10-40%.16,17There are no seemingly identifiable risk factors forrelapse at present that could form the basis for selectiveintervention in this group. For the present, it appears asif the decision to operate was based on the subjectiveassessment of the involved surgeon and the fitness of agiven patient to undergo surgery. There is anaccumulating evidence in literature albeit at present of aweak nature, that the proportion relapsing withsignificant symptoms may not be large.16,18-20 This area
needs prospective randomised trials to guide thedecision-making process in these cases.
Acute cholecystitis presenting in patients with uncontrolledmedical conditions can be effectively managed withradiologically placed percutaneous tube cholecystostomyand antibiotics in over 90% of cases. Patients offeredsubsequent elective surgery need to be counselled as tothe likely difficult nature of the operation, its higherincidence of conversion to an open procedure, andcomplication rate.
CONCLUSION
Percutaneous cholecystostomy is a good alternative forpatients unfit to undergo immediate surgery. Recurrenceof symptoms after tube removal are in a low range;therefore, it can be considered a definitive managementfor high risk patients. Laparoscopic cholecystectomyafter tube placement becomes technically challenging.
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